News
SNES
3.940
+31.33%
0.940
SenesTech Price Target Raised to $10.00/Share From $3.50 by HC Wainwright & Co.
Dow Jones · 10h ago
HC Wainwright & Co. Reiterates Buy on SenesTech, Raises Price Target to $10
Benzinga · 10h ago
SenesTech Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 1d ago
HC Wainwright & Co. Maintains Buy on SenesTech, Raises Price Target to $10
Benzinga · 1d ago
SENESTECH INC <SNES.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $10 FROM $3.5
Reuters · 1d ago
SenesTech price target raised to $10 at H.C. Wainwright to reflect reverse split
TipRanks · 1d ago
Weekly Report: what happened at SNES last week (1202-1206)?
Weekly Report · 4d ago
Weekly Report: what happened at SNES last week (1125-1129)?
Weekly Report · 12/02 09:40
Weekly Report: what happened at SNES last week (1118-1122)?
Weekly Report · 11/25 09:38
Weekly Report: what happened at SNES last week (1111-1115)?
Weekly Report · 11/18 09:37
Senestech Inc reports results for the quarter ended September 30 - Earnings Summary
Reuters · 11/13 14:16
SENESTECH, INC. FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024
Press release · 11/13 04:06
SenesTech GAAP EPS of -$2.07 beats by $1.13, revenue of $0.48M misses by $0.1M
Seeking Alpha · 11/12 21:53
SenesTech Q3 EPS $(2.07) Up From $(55.93) YoY, Sales $482.00K Miss $580.00K Estimate
Benzinga · 11/12 21:29
*SenesTech 3Q Loss/Shr $2.07 >SNES
Dow Jones · 11/12 21:05
Earnings Scheduled For November 12, 2024
Benzinga · 11/12 08:32
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 11/11 21:09
Insights into SenesTech's Upcoming Earnings
Benzinga · 11/11 18:01
Weekly Report: what happened at SNES last week (1104-1108)?
Weekly Report · 11/11 09:41
QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates
NASDAQ · 11/07 23:40
More
Webull provides a variety of real-time SNES stock news. You can receive the latest news about Senestech Inc through multiple platforms. This information may help you make smarter investment decisions.
About SNES
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The Company's technology can also be applied to other mammalian species.